Source:http://linkedlifedata.com/resource/pubmed/id/12058710
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-6-11
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1060-0280
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1108-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12058710-Administration, Oral,
pubmed-meshheading:12058710-Area Under Curve,
pubmed-meshheading:12058710-Biological Availability,
pubmed-meshheading:12058710-Dexamethasone,
pubmed-meshheading:12058710-Humans,
pubmed-meshheading:12058710-Injections, Intravenous,
pubmed-meshheading:12058710-Pemphigus
|
pubmed:year |
2002
|
pubmed:articleTitle |
Dexamethasone pharmacokinetics after high-dose oral therapy for pemphigus.
|
pubmed:publicationType |
Letter
|